Literature DB >> 24510761

Local strategies to prevent and treat osteoporosis.

F Brennan Torstrick1, Robert E Guldberg.   

Abstract

Despite advances in systemic osteoporosis therapeutic outcomes, management of fragility fractures and implant fixation in osteoporotic bone remain difficult clinical challenges. Low initial bone density and a prolonged healing response can lead to fracture nonunion and aseptic implant loosening. Local treatment strategies could be used to prevent fracture, accelerate healing, and increase implant fixation by locally stimulating anabolic pathways or inhibiting catabolic pathways. Local strategies under investigation include direct drug release from injectable materials or implant surface coatings. Common locally delivered drugs include bisphosphonates, parathyroid hormone, and bone morphogenetic proteins, yet additional compounds targeting novel pathways in bone biology are also being actively explored. Mechanical stimulation via low intensity pulsed ultrasound, alone or in combination with drug therapy, may also prove effective to promote local bone healing and implant fixation within osteoporotic bone.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24510761     DOI: 10.1007/s11914-014-0191-6

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  76 in total

1.  The action of low-intensity pulsed ultrasound in bones of osteopenic rats.

Authors:  Daniela C L Carvalho; Alberto Cliquet Júnior
Journal:  Artif Organs       Date:  2004-01       Impact factor: 3.094

2.  Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption.

Authors:  A Sabokbar; Y Fujikawa; D W Murray; N A Athanasou
Journal:  Ann Rheum Dis       Date:  1998-10       Impact factor: 19.103

3.  LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

Authors:  Y Gong; R B Slee; N Fukai; G Rawadi; S Roman-Roman; A M Reginato; H Wang; T Cundy; F H Glorieux; D Lev; M Zacharin; K Oexle; J Marcelino; W Suwairi; S Heeger; G Sabatakos; S Apte; W N Adkins; J Allgrove; M Arslan-Kirchner; J A Batch; P Beighton; G C Black; R G Boles; L M Boon; C Borrone; H G Brunner; G F Carle; B Dallapiccola; A De Paepe; B Floege; M L Halfhide; B Hall; R C Hennekam; T Hirose; A Jans; H Jüppner; C A Kim; K Keppler-Noreuil; A Kohlschuetter; D LaCombe; M Lambert; E Lemyre; T Letteboer; L Peltonen; R S Ramesar; M Romanengo; H Somer; E Steichen-Gersdorf; B Steinmann; B Sullivan; A Superti-Furga; W Swoboda; M J van den Boogaard; W Van Hul; M Vikkula; M Votruba; B Zabel; T Garcia; R Baron; B R Olsen; M L Warman
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

4.  Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

Authors:  Russel Burge; Bess Dawson-Hughes; Daniel H Solomon; John B Wong; Alison King; Anna Tosteson
Journal:  J Bone Miner Res       Date:  2007-03       Impact factor: 6.741

5.  Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency.

Authors:  B D Gelb; G P Shi; H A Chapman; R J Desnick
Journal:  Science       Date:  1996-08-30       Impact factor: 47.728

6.  Bisphosphonate use and atypical fractures of the femoral shaft.

Authors:  Jörg Schilcher; Karl Michaëlsson; Per Aspenberg
Journal:  N Engl J Med       Date:  2011-05-05       Impact factor: 91.245

7.  Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

Authors:  Dennis M Black; Pierre D Delmas; Richard Eastell; Ian R Reid; Steven Boonen; Jane A Cauley; Felicia Cosman; Péter Lakatos; Ping Chung Leung; Zulema Man; Carlos Mautalen; Peter Mesenbrink; Huilin Hu; John Caminis; Karen Tong; Theresa Rosario-Jansen; Joel Krasnow; Trisha F Hue; Deborah Sellmeyer; Erik Fink Eriksen; Steven R Cummings
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

Review 8.  Adherence with medications used to treat osteoporosis: behavioral insights.

Authors:  John T Schousboe
Journal:  Curr Osteoporos Rep       Date:  2013-03       Impact factor: 5.096

9.  Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2).

Authors:  David A Wong; Anant Kumar; Sanjay Jatana; Gary Ghiselli; Katherine Wong
Journal:  Spine J       Date:  2007-11-26       Impact factor: 4.166

Review 10.  Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis.

Authors:  Mark J Bolland; Alison Avenell; John A Baron; Andrew Grey; Graeme S MacLennan; Greg D Gamble; Ian R Reid
Journal:  BMJ       Date:  2010-07-29
View more
  3 in total

1.  Reversing the imbalance in bone homeostasis via sustained release of SIRT-1 agonist to promote bone healing under osteoporotic condition.

Authors:  Wei Zhang; Xingzhi Zhou; Weiduo Hou; Erman Chen; Chenyi Ye; Mo Chen; Qian Lu; Xiaohua Yu; Weixu Li
Journal:  Bioact Mater       Date:  2022-05-02

2.  CR6-interacting factor-1 contributes to osteoclastogenesis by inducing receptor activator of nuclear factor κB ligand after radiation.

Authors:  Li-Xin Xiang; Qian Ran; Li Chen; Yang Xiang; Feng-Jie Li; Xiao-Mei Zhang; Yan-Ni Xiao; Ling-Yun Zou; Jiang F Zhong; Shengwen Calvin Li; Zhong-Jun Li
Journal:  World J Stem Cells       Date:  2020-03-26       Impact factor: 5.326

3.  Effect of weekly teriparatide injections on osteoporotic fracture healing: protocol for a double-blind, randomised controlled trial.

Authors:  Junxiong Zhu; Chenggui Zhang; Jialin Jia; Wanqiong Yuan; Min Zhang; Huijie Leng; Chunli Song
Journal:  BMJ Open       Date:  2021-04-01       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.